Valuation : Berkley Renewables Inc.

Market Cap 4L 3L 3L 3L 5L 3.48Cr 5L 35.31L 13.58L 1.77Cr 13.69L 13.39L 5.6Cr P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 51.26L 44.16L 41.82L 37.9L 71.11L 49Cr 71.47L 4.97Cr 1.91Cr 25Cr 1.92Cr 1.88Cr 79Cr EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 20/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 17/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 5L
+0.23%+2.30%+48.60%+11.59% 17TCr
-0.44%-0.66%+60.43%+57.96% 10TCr
-0.07%+1.49%+24.71%+9.90% 7.73TCr
+0.49%+2.37%+34.57%-7.48% 6.14TCr
-0.58%+2.36%+96.28%+64.19% 6.1TCr
+0.42%+4.52%+44.46%-2.26% 5.78TCr
-0.20%+2.89%+49.74%+31.13% 5.74TCr
-0.18%+3.24%+35.67%-12.82% 4.48TCr
-2.15%+1.11%+52.51%+11.29% 3.65TCr
Average -0.25%+1.69%+49.66%+18.17% 6.64TCr
Weighted average by Cap. -0.14%+1.79%+49.82%+20.47%

Financials

2016 2017
Net sales 10.34L 9L 8L 8L 14.34L 9.88Cr 14.42L 1Cr 38.53L 5.03Cr 38.83L 37.98L 16Cr 17.25L 14.86L 14.07L 12.75L 23.93L 16Cr 24.05L 1.67Cr 64.26L 8.38Cr 64.78L 63.35L 26Cr
Net income 2L 1L 1L 1L 2L 1.65Cr 2L 16.73L 6L 83.94L 6L 6L 2.65Cr -6L -5L -5L -5L -9L -6.02Cr -9L -61.09L -23.49L -3.06Cr -23.68L -23.16L -9.68Cr
Net Debt 29.17L 25.13L 23.8L 21.57L 40.47L 28Cr 40.67L 2.83Cr 1.09Cr 14Cr 1.1Cr 1.07Cr 45Cr 47.61L 41.02L 38.84L 35.21L 66.05L 45Cr 66.39L 4.61Cr 1.77Cr 23Cr 1.79Cr 1.75Cr 73Cr
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!